Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (131-140 of 244) with videos related to

Pageof 25
Sort By:
Cancer Immunology, Immunotherapy : CII|April 17, 2024
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myelomaSophia Stock, Luisa Fertig, Adrian Gottschlich, et al.
Blood Advances|January 18, 2022
Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatmentFlorian Schoeberl, Steffen Tiedt, Anita Schmitt, et al.
Hemasphere|January 14, 2025
Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphomaSophia Stock, Veit L Bücklein, Viktoria Blumenberg, et al.
Oncotarget|April 19, 2017
Targeting CD157 in AML using a novel, Fc-engineered antibody constructChristina Krupka, Felix S Lichtenegger, Thomas Köhnke, et al.
Leukemia|January 11, 2024
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessmentGerulf Hänel, Anne Schönle, Anne-Sophie Neumann, et al.
Blood Advances|January 5, 2024
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortalityKai Rejeski, Yucai Wang, Doris K Hansen, et al.
Infection|January 17, 2025
Predicting work ability impairment in post COVID-19 patients: a machine learning model based on clinical parametersTarek Jebrini, Michael Ruzicka, Felix Völk, et al.
Hemasphere|February 19, 2021
Immune Checkpoint Blockade for Aspergillosis and Mucormycosis CoinfectionJan Christoph Banck, Niklas Mueller, Sibylle Christiane Mellinghoff, et al.
Oncology Research and Treatment|January 10, 2024
Management of Patients Undergoing CAR-T Cell Therapy in GermanyOlaf Penack, Peter Dreger, Salem Ajib, et al.
JAMA Oncology|June 18, 2026
Second Primary Malignant Neoplasms After T-Cell-Engaging Bispecific Antibody Therapy: A Systematic Review and Meta-AnalysisJaromir Tomasik, Tobias Tix, Mohammad Alhomoud, et al.
Pageof 25

Showing results (131-140 of 244) with videos related to

Sort By:
Pageof 25
Cancer Immunology, Immunotherapy : CII|April 17, 2024
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myelomaSophia Stock, Luisa Fertig, Adrian Gottschlich, et al.
Blood Advances|January 18, 2022
Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatmentFlorian Schoeberl, Steffen Tiedt, Anita Schmitt, et al.
Hemasphere|January 14, 2025
Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphomaSophia Stock, Veit L Bücklein, Viktoria Blumenberg, et al.
Oncotarget|April 19, 2017
Targeting CD157 in AML using a novel, Fc-engineered antibody constructChristina Krupka, Felix S Lichtenegger, Thomas Köhnke, et al.
Leukemia|January 11, 2024
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessmentGerulf Hänel, Anne Schönle, Anne-Sophie Neumann, et al.
Blood Advances|January 5, 2024
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortalityKai Rejeski, Yucai Wang, Doris K Hansen, et al.
Infection|January 17, 2025
Predicting work ability impairment in post COVID-19 patients: a machine learning model based on clinical parametersTarek Jebrini, Michael Ruzicka, Felix Völk, et al.
Hemasphere|February 19, 2021
Immune Checkpoint Blockade for Aspergillosis and Mucormycosis CoinfectionJan Christoph Banck, Niklas Mueller, Sibylle Christiane Mellinghoff, et al.
Oncology Research and Treatment|January 10, 2024
Management of Patients Undergoing CAR-T Cell Therapy in GermanyOlaf Penack, Peter Dreger, Salem Ajib, et al.
JAMA Oncology|June 18, 2026
Second Primary Malignant Neoplasms After T-Cell-Engaging Bispecific Antibody Therapy: A Systematic Review and Meta-AnalysisJaromir Tomasik, Tobias Tix, Mohammad Alhomoud, et al.
Pageof 25